Assessing the impact of mutations and NPI interventions for curbing Covid infection using renewal process

The COVID-19 pandemic, stemming from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially emerged in December 2019 in Wuhan city, Hubei province, China, and swiftly spread worldwide. India, too, faced a significant impact from this viral disease. In response to the escalating number of infections and fatalities, and with the aim of ensuring the healthcare system's capacity to treat severe cases, the Government of India, like many other nations, implemented, or is in the process of implementing, measures to curb the spread of the virus.